Quinolinones as prostaglandin receptor ligands

Details for Australian Patent Application No. 2002350315 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Girard, Yves; Dube, Daniel; Fortin, Rejean; Deschenes, Denis

Agent Spruson & Ferguson

Pub. Number AU-B-2002350315

PCT Number PCT/CA02/01914

PCT Pub. Number WO2003/051878

Priority 60/340,439 14.12.01 US

Filing date 11 December 2002

Wipo publication date 30 June 2003

Acceptance publication date 22 May 2008

International Classifications

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/00 (2006.01)

A61K 31/437 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/16 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/06 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/340,439 14.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002350315

16 March 2006 Assignment before Grant

  Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

22 May 2008 Application Accepted

  Published as AU-B-2002350315

18 September 2008 Standard Patent Sealed

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002350316-ADSORPTION OF CONTAMINANTS FROM GASEOUS STREAM AND IN SITU REGENERATION OF SORBENT

2002350314-CAN END